ACM
TMO icon

Aquatic Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Aquatic Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.4M Sell
29,389
-39,691
-57% -$21.5M 0.42% 49
2025
Q4 		$40M Sell
69,080
-30,631
-31% -$17.3M 1.14% 4
2025
Q3 		$48.4M Sell
99,711
-47,211
-32% -$22M 0.9% 10
2025
Q2 		$59.6M Buy
146,922
+67,090
+84% +$28.1M 1.2% 1
2025
Q1 		$39.7M Buy
79,832
+24,884
+45% +$13.5M 1.01% 7
2024
Q4 		$28.6M Buy
+54,948
New +$30.2M 0.77% 18
2024
Q3 		– Sell
-53,480
Closed -$29.6M – 1546
2024
Q2 		$29.6M Buy
53,480
+31,880
+148% +$18.3M 1.09% 17
2024
Q1 		$12.6M Sell
21,600
-7,760
-26% -$4.35M 0.41% 61
2023
Q4 		$15.6M Buy
29,360
+15,240
+108% +$7.38M 0.4% 66
2023
Q3 		$7.15M Sell
14,120
-14,680
-51% -$7.82M 0.3% 86
2023
Q2 		$15M Buy
28,800
+19,700
+216% +$10.6M 0.81% 26
2023
Q1 		$5.25M Sell
9,100
-1,300
-13% -$733K 0.32% 88
2022
Q4 		$5.73M Buy
10,400
+5,600
+117% +$2.97M 0.42% 50
2022
Q3 		$2.44M Buy
+4,800
New +$2.69M 0.24% 116
2022
Q1 		– Sell
-600
Closed -$400K – 1526
2021
Q4 		$400K Buy
+600
New +$375K 0.77% 6

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Aquatic Capital Management's TMO Position: Q1 2026 in Review

Aquatic Capital Management reduced its Thermo Fisher Scientific (TMO) stake by 57% in Q1 2026, selling an estimated $21.5M and leaving 29,389 shares worth $14.4M. The position accounts for 0.42% of the portfolio, ranked #49.

Aquatic Capital Management first reported a position in TMO in Q4 2021 and has held it in 15 quarters since. The position peaked at $59.6M in Q2 2025. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Aquatic Capital Management held 29,389 shares of Thermo Fisher Scientific worth $14.4M as of Q1 2026.
  • Aquatic Capital Management sold 39,691 Thermo Fisher Scientific shares in Q1 2026, an estimated $21.5M.
  • Thermo Fisher Scientific made up 0.42% of Aquatic Capital Management's portfolio in Q1 2026, its #49 holding.
  • Aquatic Capital Management first reported a position in Thermo Fisher Scientific in Q4 2021 and has held it in 15 quarters since.
  • Aquatic Capital Management's Thermo Fisher Scientific position peaked at $59.6M in Q2 2025.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Aquatic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.